Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Postgraduate Institute of Medical Education and Research |
---|---|
Information provided by: | Postgraduate Institute of Medical Education and Research |
ClinicalTrials.gov Identifier: | NCT00395941 |
Acitretin, when given in combiantion with pioglitazone might achieve better and/or more rapid control of moderate to severe chronic plaque type psoriasis.
Condition | Intervention | Phase |
---|---|---|
Psoriasis |
Drug: Pioglitazone |
Phase II |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study |
Ages Eligible for Study: | 18 Years to 65 Years |
Genders Eligible for Study: | Both |
Inclusion Criteria:
Exclusion Criteria:
Contact: Samir Malhotra, MD, DM | +91-172-2755243 | samirmalhotra345@yahoo.com |
India | |
PGIMER | |
Chandigarh, India, 160012 |
Study Chair: | Sunil Dogra, MD | PGIMER |
Study ID Numbers: | Pharma 6/699 |
Study First Received: | November 3, 2006 |
Last Updated: | November 3, 2006 |
ClinicalTrials.gov Identifier: | NCT00395941 History of Changes |
Health Authority: | India : PGIMER |
Hypoglycemic Agents Pioglitazone Skin Diseases |
Psoriasis Acitretin Skin Diseases, Papulosquamous |
Hypoglycemic Agents Pioglitazone Skin Diseases Psoriasis |
Physiological Effects of Drugs Skin Diseases, Papulosquamous Pharmacologic Actions |